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Leishmania spp., protozoan parasites with a digenetic life cycle, cause a spectrum of diseases in
humans. Recently several Leishmania spp. have been sequenced which significantly boosted the
number and quality of proteomic studies conducted. Here a historic review will summarize work of
the pre-genomic era and then focus on studies after genome information became available. Firstly
works comparing the different life cycle stages, in order to identify stage specific proteins, will be
discussed. Identifying of post-translational modifications by proteomics especially phosphorylation
events will be discussed. Further the contribution of proteomics to the understanding of the
molecular mechanism of drug resistance and the investigation of immunogenic proteins for the
identification of vaccine candidates will be summarized. Approaches of how potentially secreted
proteins were identified are discussed. So far 30 – 35% of the total predicted proteome of
Leishmania spp. has been identified. This comprises mainly the abundant proteins, therefore the last
section will look into technological approaches how this coverage may be increased and what the
gel-free and gel-based proteomics have to offer will be compared.
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Introduction:
Genomics and transcriptomics were until recently unmatched in their power to enable highly parallel
insight into the biology of cells and organisms. However, proteomics and more recently
metabolomics have come of age and contribute and expand this knowledge.
The idea that mRNA levels are indicators of the respective protein expression/abundance, is often
untrue and mRNA abundance can be misleading1, 2 and do not inform about post-translational
protein modifications that can dramatically change protein function. This is especially true for the
trypanosomatids as these organisms regulate their protein expression and abundance post-
transcriptionally3. The three major human disease causing trypanosomatids - conveniently referred
to as TriTryps - are unicellular organisms of the genera Leishmania spp. and Trypanosoma brucei and
Trypanosoma cruzi which cause morbidity and mortality in humans and life stock in the middle East,
south and south-east Asia, middle and South-America as well as countries surrounding the
Mediterranean sea and sub-Saharan Africa (data from WHO). Leishmania the causative agent of the
leishmaniases has as the other trypanosomatids a digenetic life cycle and oscillates between the
extracellular promastigote form transmitted by sand flies and the intracellular amastigote form
occurring in vertebrate hosts. Currently there are 350 million people at risk of leishmaniases with a
prevalence of 12 million people and an estimated 1.5 – 2 million new infections each year. There are
60,000 – 70,000 deaths each year mostly due to the most severe form of the leishmaniases the
visceral leishmaniasis caused by L. donovani in India but also by L. infantum in northern Africa and
southern Europe4, 5. For a detailed review on Leishmania transmission and distribution see Alexander
et al. and Reithinger et al. respectively4, 5. Less severe disease outcomes are the mucocutaneous and
the cutaneous leishmaniasis caused by L. braziliensis and L. major as well as L. mexicana,
respectively.
Here, we like to review the information available on the proteome of Leishmania spp., a field that
has greatly advanced since the genomic information became available in 20056 and complement a
recent review on proteomics of TriTryps7 by the latest data.
The focus will be a historical review of how proteomics in Leishmania spp. advanced over time and
its contribution to the understanding of molecular changes in the different life cycle stages, drug
resistance and to the identification of vaccine candidates and novel drug targets.
Leishmania spp. proteome profiling in pre-genomic era
Leishmania spp. have a core genome of 8178 genes shared between the three currently sequenced
and annotated genomes of L. major, L. infantum and L. braziliensis, and only few genes are species
specific, 5, 27 and 49, respectively8. Although it is known that host factors play also a part in disease
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outcome, it is reasonable to assume that for the course of an infection differences in gene content
or expression level in parasite species and isolates determine their respective virulence. Since the
parasites regulate gene expression mainly at post-transcriptional stages, proteomics is thought to
yield critical insight into the mechanisms of stage differentiation, species differences, virulence and
drug resistance.
The first proteome maps of Leishmania were published in the early 1980s9-11 long before the term
proteomics was coined12. Handman et al. as well as Saravia and colleagues were investigating
species differences and virulence factors9-11. However, at the time no protein was identified as mass
spectrometric technologies were not yet developed for large biomolecules, the genome/s of
Leishmania were not yet sequenced and identifications were relying on for example Edman
degradation. Identification of large biomolecules became only possible from the late 1980s onwards
when two groups independently of each other developed matrix assisted laser desorption/ionization
– time of flight (MALDI-TOF)13, 14 analyses. The spectrum of analysis methods was then widened by
the development of electrospray ionization (ESI)15. Several studies have led to stepwise
improvement of methodology to investigate the parasites’ proteomes. Suitable lysis methods of
Leishmania to resolve as many protein-species as possible were identified16. A number of detailed
2DE proteome maps were then produced. For example, Brobey and colleagues reported normalized
maps with 1650 and 1530 protein spots for L. amazonensis and L. major, respectively and showed 4
of these as only present in L. amazonensis17. Similarly, Gongora and colleagues produced highly
resolved proteome 2DE maps of L. (Viannia) guyanensis and L. (Viannia) panamensis promastigotes18
and identified ‘landmark protein spots’. These landmark protein spots were analysed by mass
spectrometry and identified as 2 isoforms of heat shock protein 70 (hsp70), chaperonin (hsp60),
ribosomal protein S12, kinetoplastid membrane protein 11 and a 13 kDa small myristoylated
protein-3, putative (annotated as hypothetical at the time)18. This enabled a comparison with clones
of L. guyanensis that differed in metastatic capacities highlighting four protein species that may be
involved in the different biologic behaviour18.
However, it was the sequencing of the genomes of L. major6, L. infantum and L. braziliensis8, with
data available since the beginning of this millennium that enabled the relatively straight forward
identification of protein-species excised from 2DE gels by mass spectrometry or from peptides
separated by liquid chromatography (LC) as discussed below.
Identification of life cycle stage specific proteins
To understand the differences during transformation and between the different life-cycle stages on
the molecular level several groups resolved the proteome of L. infantum, L. donovani and L.
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mexicana promastigotes and amastigotes19-21 and promastigotes upon reception of the
transformation signal22 or metacylics23.
A first study analysing protein spots excised from 2D gels by mass spectrometry investigated the
different life cycle stages of L. infantum (promastigotes and axenic amastigotes) and 62 proteins
species were reported to be differentially expressed 19. Genomes of L. major6, L. infantum and L.
braziliensis8 were not available at the time and obtained amino acid sequences were used for
identification of homologous proteins by using the BLAST search algorithm that requires a very high
degree of sequence conservation to unambiguously identify a protein, hence only two proteins
(isocitrate dehydrogenase and triosephosphate isomerase) could be identified. Later the GeneDB
database became publicly available which provided a platform for initially the L. major genome and
later for all sequenced genomes24. This presented a great ease for the field in general and led to a
dramatic increase in studies conducted and proteins identified of Leishmania spp. (see also Figure.
1). For example, analysis of 101 protein spots of L. braziliensis promastigtotes revealed that they
originated from 75 genes25. The transformation from promastigotes to axenic amastigotes of L.
donovani was investigated by Bente et al. and 115 regulated proteins species were reported.
Analysis of the transformation process in L. mexicana revealed 147 regulated protein species23. Stage
specific differences in protein species abundance were detected in L. panamensis20, where in axenic
amastigotes 75 proteins species showed differential expression and in promastigotes 45 were solely
detected or upregulated. A method to isolate truly intracellular amastigotes from infected bone
marrow derived macrophages and lesions to perform proteomics was developed and reported by
Paape and colleagues21. The authors used DsRed expressing L. mexicana promastigotes to infect
BALB/c mice or axenic amastigotes to infect macrophages. Amastigotes were purified and depleted
of host cell material by fluorescent activated cell sorting by positive selection for the DsRed
expressing parasites while at the same time selecting negatively for the main host cell contaminants,
nucleic material using DAPI fluorescence as a negative selectable marker. The subsequent proteomic
analysis revealed 34 proteins solely detected in amastigotes21. Proteomes of L. major26 and L.
braziliensis25 promastigotes were also analysed and methods to increase proteome coverage were
investigated. Drummelsmith and colleagues extended the 2DE technique by performing IEF over
narrower but overlapping pH ranges and resolved a total of 3696 distinct L. major protein spots.
Several were mass spectrometrically analysed and 37 protein spots were identified as 29 proteins26.
These studies highlight the fact that between the different life-cycle stages are “subtle” differences,
protein species of similar MW or pI originating from the same gene, but also major differences in
protein expression, up- or down regulation of expression and stage specific expression. Most of
these studies produced 2DE maps to visualize and detect especially “subtle” differences that may be
due to post-translational modifications (PTMs) affecting charged amino acids. Although more
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proteins may be identified by gel free approaches (see below) these 2DE maps will continue to
provide a significant resource that can help to identify changes at the protein species level.
The current most comprehensive study investigating the molecular changes at the proteome level
during differentiation of L. donovani promastigotes to axenic amastigotes were carried out by
Rosenzweig and colleagues27 in the first gel free proteome study in Leishmania spp. This approach
allowed to obtain higher proteome coverage and more precise quantitative information. Peptides of
the digested proteome were labelled by the ‘isobaric tags for relative and absolute quantification
(iTRAQ) method, this allowed the comparison of up to four proteomes at a time and determine
changes in relative abundance of proteins over the course of differentiation. Parasites were
harvested at 2.5, 5, 10, 15 and 24h post differentiation signal (pH 5.5 and 37 °C) and as axenic
amastigotes (6 d post differentiation signal) and the proteome of these stages were compared by
multidimensional LC-MS. In total, 1713 proteins could be identified, with 931 confirmed in biological
repeats representing ~21% of the predicted L. infantum proteome. Of the identified proteins 934
had a known or predicted function and 779 had no known function. Almost 56% (969) of the
identified proteins were expressed at all stages, with 289 gradually increased, 310 gradually
decreased in abundance as parasites transformed from pro- into amastigotes. The other 370 were
either not affected or expression increased and then decreased again. Many enzymes of the major
metabolic pathways were identified and their expression pattern was analysed. Expression of
glycosomal glycolytic enzymes increased in amastigotes whereas cytosolic glycolytic enzymes
decreased suggesting a reduced glycolysis in amastigotes confirming early biochemical analyses
using ex vivo prepared amastigotes28. The glycosomal glycolytic enzymes are likely involved in
gluconeogenesis, the glcosomal gluconegenic enzymes pyruvate phosphate, dikinase
phosphoenolpyruvate carboxykinase and fructose 1,6-bis-phospahtase were also higher expressed in
axenic amastigotes. Transamination of alanine could provide a source for pyruvate in the
glyconeogenesis and the respective enzyme alanine aminotransfearase was found upregulated in
axenic amastigotes. Enzymes involved in β-oxidation, the tricarboxylic acid cycle, mitochondrial
respiration/ oxidative phosphorylation and amino acid catabolism were expressed at a higher level in
axenic amastigotes. It was observed that the abundance of enzymes involved in pentose phosphate
metabolism in axenic amastigotes was decreased.
Proteins involved in translation (ribosomal proteins, translation elongation and initiation factors and
tRNA-synthetases) remained unaltered in expression for the initial differentiation period (up to 10h)
and then decreased in their abundance. Histones only increased in expression in the later stages of
differentiation, post 10h. Of 10 detected calpain proteases, five decreased and three increased in
abundance in axenic amastigotes, indicating a developmental switch in the predominant expression
of calpains. Nineteen heat shock proteins and chaperones were identified which differed in their
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expression levels, some increased in the initial differentiation period and returned then to
promastigote levels or below, others did not change until later in differentiation when their
expression returned to promastigote levels or below. A minor group also gradually decreased in
abundance throughout differentiation and only hsp100 gradually increased in its expression. Also 20
proteins were reported to be up-regulated by more than 2-fold as early as 2.5h post differentiation
signal, 13 of these have no known function, the others being D1 myo-inositol transporter, universal
minicircle sequence binding protein, flavoprotein subunit-like protein, methionine synthetase, h1
histone-like, kinetoplast-associated protein-like protein and ascorbate-dependent peroxidase27. This
work clearly boosted insight into the molecular changes during the differentiation process as the
parasite adapts to its new hostile environment within the lysosome-like parasitophorous vacuole.
The most dramatic changes in protein abundance only occurred late in the transformation 24 – 144h
post transformation signal.
The fluorescence based purification approach21 was developed further for gel free proteomic
analysis29. Thereby 1764 (~22% of theoretical Leishmania spp. proteome) proteins could be
identified. Moreover, by adapting a label free algorithm to derive relative abundance values of the
identified proteins, protein abundance data could be integrated e.g. into the in silico metabolic
pathway map curated for Leishmania by McConville’s group30. This approach confirmed predictions
about metabolic adaptations to the intracellular habitat21, 29. The further integration of ‘omics’ data
sets has just begun to yield interesting insight31 and in combination with metabolic network
analyses32 will be very revealing in the future. Furthermore for the first time the experimental data21
confirmed the presence of a codon bias in these Leishmania21, which is of importance when
Leishmania spp. is used as an expression platform33.
Phosphoproteomics and parasite differentiation
Post-translational modifications alter or extend the function and stability of the modified protein, it
can further also influence its localization within the cell, hence identification and the implication of
PTMs on a large scale became into recent focus.
Phosphorylation/dephosphorylation of proteins by kinases/phosphatases at serine, threonine and/
or tyrosine residue/s is a very important PTM. This regulatory element mediates signal transduction
in the cell, activation/deactivation of proteins/enzymes, protein-protein interactions and also
protein turn-over. This led to the hypothesis that phosphorylation is also an important mechanism
involved in receiving/mediating the differentiation signal when the parasites is transmitted and has
to adapt to a new environment. The importance of it was shown for a protein-tyrosine phosphatase
from L. donovani were promastigotes and axenic amastigotes devoid of both alleles were mostly
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unaffected in growth and differentiation but parasites were severely attenuated in their ability to
establish themselves in the spleen or liver of BALB/c mice34.
Morales and colleagues published the first analysis of the phosphoproteome of Leishmania35.
Phosphoproteins of L. donovani promastigotes and axenic amastigotes in logarithmic growth phase
were enriched by immobilized metal affinity chromatography (IMAC) and proteomes separated by
2DE, the resulting gels were stained with ProQ diamond, a phosphoprotein specific stain, and for
total proteins. In total 73 phosphoproteins were identified, corresponding to 55 proteins with an
annotated function and 18 proteins annotated as hypothetical. It was also reported that in
amastigotes relatively more proteins were phosphorylated compared to promastigotes 4% and 2.6%
of total protein content, respectively35. The identified proteins were classified in five functional
groups: 1) stress and heat shock response; 2) RNA turnover, ribosomal biogenesis and protein
degradation; 3) signalling; 4) metabolic processes and others and 5) hypothetical proteins. The
authors also reported stage specific phosphorylation events with differential abundance of
phosphoproteins, e.g. HSP-83, RNA helicase and glucose-6 phosphate dehydrogenase were
upregualted in amastigotes whereas the protein phosphatase LmjF05.0100 was 3-fold upregulated
in promastigotes; different isoforms in either life cycle stage and proteins exclusively phosphorylated
in amastigotes, e.g. HSP100, Leishmania MAP kinase homolog LmaMPK10 and nucleotide
diphosphate kinase b. Analysing of iTRAQ labelled L. donovani promastigotes and axenic amastigote
peptides27 was performed to detect PTMs of amino acid residues36. This lead to the identification of
16 phosphorylated, 20 methylated, 26 acetylated and 13 glycosylated (fucosylated and hexosylated)
peptides. This also implicated the involvement of phosphorylation events in the stress response,
RNA and protein turnover36.
Further differences in the phosphorylation were revealed by comparison of L. donovani
promastioges and axenic amastigotes of IMAC enriched phospoproteome by 2D-differential gel
electrophoresis37. In total 813 protein spots were detected with more than 700 present in three
biological repeats. Of these 171 could be identified containing 55 not present in the previous study35.
Yeast orthologs of the obtained dataset were analysed with respect to their gene ontology (GO), this
revealed six statistically significant GO categories to be overrepresented translation initiation,
protein folding and catabolism, chromosome organization and biogenesis, organellar fusion and
amino acid metabolism. Differential phosphorylation was observed for 318 protein spots,
corresponding to 38% of the detected phosphoproteins. Amastigote proteins increasing in
abundance/phosphorylation were almost exclusively protein chaperones e.g. HSP90/HSP83, HSP70
family members and stress induced protein STI137. Phosphorylation of HSPs might be involved in the
regulation of HSP function in the parasite. For example, a highly conserved aspartic acid seen in the
mouse or human HSP90 homologue is substituted by a serine that becomes phosporylated in
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amastigotes. The aspartic acid is proposed to correspond to a constitutive phosphorylation that locks
the protein in a functionally distinct conformation.
In amastigotes the presence of a multimeric chaperone complex interacting with ribosomal proteins
was reported with STI1 playing a crucial role in its formation. The complex might be involved in the
control of protein translation37 or simply provide a platform of translation and formation of correctly
folded proteins. Three phosphorylation sites of STI were identified (residues S15, T217 and S481)
with residues S15 and S481 required for L. donovani viability in culture highlighting the significance
of chaperone phosphorylation in the parasite37.
The same group also analysed the phosphoproteome of L. donovani axenic amastigotes by gel free
mass spectrometry. In two biological repeats 445 putative phosphoproteins were identified with
48% annotated as hypothetical proteins. Based on S. cerevisiae orthologs (239) proteins were
classified in functional GO categories with evidence for enrichment of the following biological
processes: protein transport, translation, translation initiation, protein degradation and stress
response. To verify for phosphorylation sites phophoprotein fractions were enriched for
phophopeptides post trypsin digest on TiO2-columns. Phosphopeptides were then analysed by 2D
LC-MS/MS analysis and 126 proteins with 181 phophorylation sites were identified38. Serine residues
were most frequently phosphorylated followed by threonine and tyrosine residues, 86%, 12% and
2%, respectively, a figure becoming more accurate with a larger dataset. This is in an order that
would be expected for higher eukaryotes39 but it is substantially different from T. brucei and T. cruzi
where about one-third of the phosphorylated residues were found to be threonines 40, 41. Whether
this is of biological relevance or due to sample handling needs to be verified. Seventy eight percent
of the proteins were phosphorylated at a single site, 19% dually and 3% triple phosphorylated.
Several of the identified phosphorylation sites were not conserved or where the respective
sequence was absent in other Leishmania spp.38 maybe reflecting species differences that may be
linked to the different disease outcomes of tropisms of infection (cutaneous, visceral). The
phosphorylation sites were even less conserved in comparison to other trypanosomatids (e.g. T.
cruzi, T. brucei, T. vivax and T. congolense). Interestingly L. infantum based on this analysis is closer
related to T. cruzi than to T. brucei and T vivax. The authors speculate that this might reflect the
relevance of these sites for processes involved in intracellular survival/adaptation. On the other
hand 40% of the proteins are not present in the human genome and phosphorylation sites in 19
proteins were only present in the leishmanial homologue but not in the human protein, indicating
that the responsible kinases may be potential drug targets. This idea is currently pursued by the
Leishdrug consortium. Overall, the data suggest that PTMs are involved in the stress response in
Leishmania37, 38.
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Proteomics to study drug resistance in Leishmania spp.
Drug resistant parasites are a major problem in the field since leishmaniasis management relies on
drugs42. However, the mechanistic reasons for drug resistance are only partially understood.
Therefore several studies utilized comparative proteomics to look at the different protein expression
pattern between drug susceptible and resistant parasites to elucidate the molecular mechanism of
drug resistances.
Laboratory induced methotrexate drug resistance in L. major was investigated26. Methotrexate
inhibits dihydrofolate reductase–thymidylate synthase (DHFR-TS) and to a much lesser extend
pteridine reductase43. Comparison of 2DE maps of resistant and sensitive L. major parasite revealed
a number of differentially expressed protein spots. The most striking was the presence of a 30 kDa
protein spot with an approximate pI of 6.3 in the resistant line which was absent in the susceptible
line. This protein spot was then identified as pteridine reductase26, over-expression of it is linked to
methotrexate resistance44, 45. This was investigated in more depth in another comparative proteome
study of L. major wt and two independent in vitro derived methotrexate resistant strains. Proteomes
were resolved and 16 protein spots were analysed of which intensity differed by more than 2-fold in
at least one of the two resistant strains when compared to the wild type parasites. Fifteen protein
species, encoded by 14 genes, could be identified; interestingly some protein species were only
present in one resistant strain but not the other, e.g. pteridine reductase 1 and argininosuccinate
synthase, in one, and acyl-coa-dehydrogenase in the other strain46. Over-expression of
argininosuccinate synthase and acyl-coa-dehydrogenase was the result of gene locus amplification
events of genes in close structural proximity linked to methotrexate resistance pteridine reductase 1
and DHFR-TS, respectively. DHFR-TS is the primary target of methotrexate47 and gene amplification is
one mechanism to respond to drug pressure48, 49.
It was also reported that enolase and S-adenosylmethionine synthetase were expressed at higher
levels in resistant strains indicating that some responses to methotrexate selection pressure are
conserved. The authors hypothesized that these differences constituted an early response to
methotrexate exposure rather than resistance and compared the proteome of wild type parasites
exposed for 24 h to an EC50 concentration of methotrexate with that of not exposed parasites. This
comparison identified proteins belonging to the stress response (thiol-specific antioxidants) and
again enolase and S-adenosylmethionine synthetase as previously detected in the resistant strains.
Enolase as other glycolytic enzymes were reported to be over-expressed in response to several
stresses like heat shock or osmotic stress50, 51. S-adenosylmethionine synthetase was linked to be
involved in the acquisition of resistance46.
Vergnes and colleagues used 2DE resolved proteomes of antimony [Sb(V)] resistant and susceptible
Indian field isolates52 to study resistance to this drug in L. donovani. In total 11 protein species were
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identified seven up-regulated (heat shock protein 83; hsp70-related protein 1, mitochondrial
precursor, chaperonin containing tcp1, subunit 8; 14-3-3 protein; ATP-dependent RNA helicase;
hSP70, dipeptidyl-peptidase III) and five down-regulated (hsp70-related protein 1, mitochondrial
precursor; hypothetical protein, unknown function; enolase, 20 S proteasome α5 subunit, SKCRP14.1
(small kinetoplastid calpain related protein)). Several of these proteins (hsp83, 14-3-3 protein and
SKCRP14.1) have reported roles in programmed cell death in a number of organisms. This led to the
hypothesis that programmed cell death is altered in the resistant strain. While over-expression of
14-3-3 did not confer resistance to Sb(V) increased hsp83 levels doubled the dose-dependent
resistance of the parasites. Interestingly hsp83 over-expressing parasites were also cross-resistant to
miltefosine. Over-expression of SKCRP14.1 increased the sensitivity to Sb(V) but decreased its
susceptibility to miltefosine52.
Sb(V) drug resistance was also investigated by comparative proteomics of Sb(V) resistant and
susceptible L. donovani53. Promastigotes were lysed, separated into a ‘membrane enriched protein’
and a cytosolic protein fraction and the proteomes resolved by 2DE. Over expressed protein spots
derived from the resistant parasites were analysed and of 12 protein spots in the membrane fraction
6 could be identified (cysteine-leucine rich protein, ABC and ABC1 transporter, hsp83, GPI protein
transamidase and 60S ribosomal protein L23a(L25)). In the cytosolic fraction 14 of 18 protein spots
originating from eight genes were identified (hsp70, carboxypeptidase, fructose-1,6-bisphosphate
aldolase, enolase, proliferative cell nuclear antigen (PCNA), proteasome alpha 5 subunit and tubulin-
beta chain)53.
Comparative proteomics was also used to study antimony resistance in L. infantum axenic
amastigote from resistant and susceptible strains to trivalent antimony [Sb(III)]54. 2DE maps were
generated and differentially expressed proteins were analysed. Several proteins were down-
regulated in the resistant parasites, LACK receptor, proteasome activator protein pa26 subunit,
pyruvate kinase, kinetoplastid membrane protein 11 (KMP-11) and β-tubulin only one protein was
over-expressed, argininosuccinate synthase. Argininosuccinate synthase is physically linked to an
ABC transporter (P-glycoprotein A / MRPA) which was reported to be involved in antimony
resistance55, 56. The reason that the latter was not identified is likely to be related to the fact that it is
a transmembrane protein which are generally under-represented in proteomic analyses. An
increased protein turnover rate of KMP-11 was observed in the resistant parasites. It was suggested
by the authors that the decreased expression/accelerated turnover rate of KMP-11 could lead to an




Increasing resistance of parasites to available drugs highlights the need for developing a vaccine.
While 1st generation whole cell vaccines have largely failed59 to show efficacy it is believed that
subunit vaccines based on selected protein antigens can be developed60. Therefore, it is important to
identify new candidate antigens and the published proteomic data sets supposedly hold a valuable
set of candidates. One good attribute for a vaccine is high abundance of the respective protein in the
pathogenically important life cycle stage, the amastigote. It is also important to understand which
leishmanial proteins are immunogenic and to what extent.
Gupta et al. analysed a fraction of soluble non-membranous L. donovani lysate of metacyclics which
induced strong T cell responses from peripheral blood cells of individuals recovered from visceral
leishmaniasis61. The proteome of the soluble non-membranous lysate was resolved by 2DE and
protein spots associated with the T-cell responses62 of 63 – 97.4 kDa and a pI range of 3-10 were
excised and mass spectrometrically analysed. In total, 63 protein spots were excised and 52 protein
species could be identified originating from 33 different genes among them were six encoding
hypothetical proteins61. Among the remaining ones there were for example heat shock proteins,
reported to induce Th-1 cytokines in peripheral blood mononuclear cells of mucocutaneous and
cutaneous leishmaniasis of infected patients63, several glycolytic enzymes, protein disulfide-
isomerase, calreticulin and kinesin-like protein (K39). In general proteins in this molecular weight
range belong to the following functional classes: stress response, cytoskeleton assembly, energy
metabolism, cell cycle control / proliferation and amino acid metabolism.
Immunogenic proteins of L. infantum promastigotes of mid-logarithmic growth phase were
investigated by Dea-Ayuela and colleagues64. To guide identification, 72 randomly chosen landmark
protein spots were analysed by mass spectrometry of which 29 could be identified. These belonged
to the following functional groups 1) carbohydrate metabolism, 2) proteolysis, 3) amino acid
metabolism (i.e. succinyl-diaminopimelate desuccinylase), 4) fatty acid metabolism, 5) structural
proteins, 6) stress response, 7) five hypothetical proteins and 8) other function (for example
adrenodoxin reductase involved in the ergosterol biosynthesis). Immuno-blots were developed with
anti-L. infantum rabbit hyperimmune sera and more than 50 protein spots between 90 and 30 kDa
were detected. Comparison with silver stained gels revealed some of the immunogenic spots as
propionyl-CoA-carboxylase, ATPase beta subunit, transketolase, a proteasome subunit, succinyl-
diaminopimelate desuccinylase, a probable tubulin alpha chain, full length hsp70 and hsp70 related
protein 1 as well as several proteins of unknown function64.
Walden and colleagues identified L. donovani antigens recognised by serum antibodies of patients
suffering from visceral leishmaniasis. Lysates of in vitro grown L. donovani promastigotes originally
isolated from patients were separated by 2DE and then analyzed by protein immuno-blot. In silver-
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stained 2D gels with a pH range of 4.5 – 7 1067 protein spots were resolved and some 330 antigenic
spots could be assigned in corresponding immuno-blots. Of these 330 antigenic spots 68 could be
unequivocally matched to the 2D gels. Six protein spots could be identified by mass-spectrometry
hsp70 (in two spots), gp63, eIF-4A, eEF2 and glucose regulated protein 78. Of note, the authors
observed a high diversity in the antibody responses of the individual patients which prompted them
to propose a recognition hierarchy for these antigens65.
A protective immune response depends on the activation of leishmanicidal mechanisms in
parasitized host cells. Reactive nitric oxide (NO) intermediates are thought to provide a main
effector mechanism but its molecular targets remain to be identified. Thus, through proteomics NO
effects, i.e. the effect of the NO donor 3-morpholinosydnonimine (SIN-1) on L. infantum
promastigotes was investigated66. Exposure of logarithmically growing promastigotes to 100 pM
SIN-1 for 6 h killed 60-80% of the parasites. Comparative proteomics of the so treated parasites and
untreated controls led to the identification of 22 proteins. Upon SIN-1 exposure enolase,
LmjF36.4910 a hypothetical protein with unknown function, 20S proteasome beta 7 subunit and P28
protein became more abundant while hsp70, LmjF36.6360 hypothetical predicted protein, 20S
proteasome alpha 5 unit and phosphomannomutase were decreased. The expression of 3-hydroxy-
3-methyglutaryl-CoA synthase, peroxidoxin precursors and prostaglandine F2α synthase was
induced. Interestingly the infectivity to J774 macrophages of promastigotes which survived the NO
exposure was significantly increased66.
Secreted Proteins by Leishmania spp.
Leishmania parasites have been shown to secrete factors that are relevant for nutrient acquisition,
for interaction with their insect vectors and their vertebrate hosts. Thus, there is considerable
interest in a comprehensive description of secreted proteins, an obvious application for proteomics.
Silverman and co-workers studied the secretome of L. donovani promastigotes by using the stable
isotope labelling of amino acids in culture (SILAC) methodology. Labelled stationary phase
promastigotes were cultured in a serum free medium for 4 – 6 h and spent supernatant of the
cultures was quantitatively compared to unlabelled proteins prepared from the pelleted cells. In
total, 358 proteins were identified and based on the quantitative SILAC analysis 151 proteins were
regarded as actively secreted. For most of these proteins the respective genes did not encode
secretion signals and the authors proposed that bulk protein secretion in Leishmania spp. is via
microvesicles, akin to exosomes, a suggestion that was further supported by electron microscopical
analyses that identified such vesicles in the vicinity of the flagellar pocket. This concept is attractive
given the implications that exosomes may have for the infection process67 but verification of it
remains technically very challenging.
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Cuervo and co-workers used 2DE to identify secreted proteins of L. braziliensis promastigotes68.
Parasites were incubated for 3 h in serum free medium and the proteins in the supernatant of spent
cultures were precipitated and subsequently subjected to 2DE. In Coomassie blue stained gels
approximately 270 protein spots were detected of which 42 were identified originating from 35
genes. Bioinformatic analyses using SignalP3.0, SecretomeP2.0 and TargetP1.1, determined the
presence or absence of signal peptides or predicted secretion via alternative pathways. Thereby 24
proteins appeared secreted via the classical (2 of 24) or non classical pathway (22 of 24). The
absence of transmembrane domains was also analysed by predictive algorithms in these 42
identified protein species. The authors concluded that there is also an unconventional bacterial
secretion pathway present in Leishmania, especially a Gram negative-like secretion pathway. The
putative secreted proteins belonged to the following functional classes: stress response/chaperones,
carbohydrate metabolism, protein synthesis, amino acid metabolism, proteolysis, antioxidants and
others (for example dihydroorotate dehydrogenase, histidine secretory acid phosphatase, IgE-
dependent histamine-releasing factor and LACK)68.
Paape et al. carried out a bioinformatic analysis assuming that protein secretion would require a
classical N-terminal signal peptide and no transmembrane nor a GPI-anchor. In their proteome data
set obtained from intracellular L. mexicana amastigotes, this approach predicted 143 secreted
proteins29. It will undoubtedly require more work to investigate further the relative contributions of
secretion signal mediated protein release versus exocytosis mechanisms but proteomics will help in
the identification.
Further developments
Shortcomings of even the most comprehensive proteomic datasets produced to date for Leishmania
spp. are a dramatic under representation of membrane proteins and, in comparison to
transcriptomic data, a lack in sensitivity. Both aspects are recognised and several groups have
investigated solutions.
Prefractionation of parasite lysates to increase proteome coverage
The disadvantage of separation highly complex mixtures by 2DE is that only abundant proteins will
be detected as less abundant proteins may be masked or not detected and their identity remains
elusive.
McNicoll and colleagues addressed this by analysing the proteomes of L. infantum promastigotes
and amastigotes after reducing sample complexity by differential ammonium sulphate precipitations
of the total lysate69. In total six fractions were obtained by collecting material precipitating at 0 –
40%, 40 – 50%, 50 – 60%, 60 – 70%, 70 – 80% and >80% ammonium sulphate concentration. The
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desalted fractions were then separated by SDS-PAGE revealing distinct protein bands, with the bulk
of proteins in the fraction from 40 – 80% ammonium sulphate that was then analysed be 2DE. The
procedure proved highly reproducible and a total of 2261 and 2273 protein spots could be resolved
for protein fractions generated from promastigotes and amastigotes respectively. Selected spots
identified 168 protein species that originated from 71 different genes69. Although fractionation
clearly enriched for different proteins its full benefit remains to be shown.
To reduce complexity and enable identification of subproteomes, Foucher and colleagues used
differential solubilization of membranes by digitonin for pre-fractionation70. Digitonin is a non-ionic
detergent which solubilizes sterols and at lower concentrations forms pores in the membrane.
Depending on the concentration and accessibility as well as sterol composition of the membrane,
different membrane types are solubilized. Further, digitonin even at higher concentration has no
effect on the cytoskeleton. This characteristic was exploited by the authors. Leishmania infantum
promastigotes and axenic amastigotes were treated with increasing concentrations (100 µM,
500 µM and 5 mM). The respective digitonin protein extracts as well as the whole cell extract and
the non-digitonin solubilized material were separated by 2DE and resulted in 1921 protein spots for
the whole cell extract. The serial digotonin extracts resolved 983, 883, 286 and 1086 protein spots
for 100 µM, 500 µM, 5 mM and the non-solubilised proteins, respectively, and resulted in largely
different protein spot pattern with little overlap. In total, 153 protein species were identified of
which 47 were hypothetical. The subcellular localisation of identified protein species extracted with
100 µM digitonin was mainly cytoplasmic and proteins known to be found in the cytoplasm or within
organelles. For the 500 µM digitonin extract the majority and for 5 mM all of the identified protein
species were predicted to reside within organelles. The digitonin non-solubilized fraction was
comprised mainly of protein species constituents of or associated with the cytoskeleton. The
depletion of tubulins in the digitonin soluble material was also confirmed by Western analysis, it was
virtually absent in the first two digitonin fractions but was detectable in the third fraction to a small
degree compared to the non-soluble material. This differential lysis protocol of Leishmania spp. and
its membranes thus may yield directly information about the likely subcellular localization of
proteins70.
Further developments included the use of prefractionation by liquid phase iso-electric focusing. L.
amazonensis promastigotes lysates were prepared using this technique in order to increase the
protein-spots of 2DE resolved proteomes and more protein species were resolved compared to only
2DE resolved proteomes71.
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Improvement in electrophoresis techniques
Brotherton and colleagues used free-flow electrophoresis (FFE) to increase proteome coverage of
basic protein species of L. infantum promastigotes and axenic amastigotes72. The lysates were
subjected to FFE and collected fractions with a basic pH were combined into two pools pH7.0 – 9.0
and pH> 9.0 and separated by 2DE. The pH 7.0-9.0 pool resulted in 1813 and 1823 resolved protein
spots for promastigotes and amastigotes, respectively, with four unique and 14 upregulated in the
extracellular stage and 15 unique and 33 upregulated in the intracellular stage. In the pooled
fractions with a pH>9.0 623 and 646 protein spots were resolved for promastigotes and amastigotes,
respectively, with seven unique and eight upregulated in the promastigote stage and five unique and
three upregulated in amastigotes. Of these differentially expressed protein spots 18 from
promastiogtes and 25 from amastigotes were analysed by mass spectrometry and resulted in the
identification of 87 and 63 protein species for pro- and amastigotes, respectively. It was also
observed at proteome level that the glycolytic enzymes were upregulated in promastigotes21, 27
whereas amastigotes express gluconeogenic enzymes and enzymes involved in β-oxidation at a
higher level as previously reported21, 27, 29. The authors reported also flagellar proteins to be over
expressed in the promastigote stage which is probably not surprising.
Gel free versus gel based proteomics
Advantage of 2DE is the visualization of “break down” products as well as “multi spot trails” due to
post translational modification. Lifecycle specific proteolytic products for α- and/or β-tubulin in
amastigotes20, 23, 46, eEF1α21, 23, 72, hsp83 and Glucose 6 phosphate dehydrogenase20, δ-1-pyrroline-5-
carboxylate dehydrogenase72, putative carboxypetidase, eIF4a and hypothetical protein LmjF08.1270
and for promastigotes putative proliferative cell nuclear antigen were reported69. Stage specific
break down products of various heat shock proteins were also observed69. Proteasome α1 subunit
was found in distinct protein spots for amastigotes and promastigotes at the same apparent pI but
slightly different apparent molecular weights. A similar observation was reported for several
different enolase isoforms some appeared to be promastigotes and some amastigote specific69.
Apparent differential post translational modifications were also reported for tryparedoxin
peroxidase and triosephosphate isomerase 72.
Thus, while gel free methods are advantageous in the detection of proteins of lower and lowest
abundance compared to gel based studies the latter still offer the advantage of being able to pre-
select protein species for analysis and visualize differences at the protein species level due to post
translational modifications that affect either size or charge of proteins.
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In total 31-35% of the Leishmania spp. proteome predicted from the genome has been identified to
date. Although this is a respectable number but the datasets still reflect mostly abundant proteins.
In order to identify the other end of the spectrum, proteins of lower to lowest abundance, better
prefractionation or selective depletion of (highly) abundant proteins are necessary as well as
improved mass spectrometry techniques and methods, but will undoubtedly be available in the near
future. Improvements seem also on the horizon to identify transmembrane proteins which are
under-represented in the current data sets more readily.
Metabolic pathways such as β-oxidation of fatty acids were already known to be upregulated in the
intracelleular life cycle stage from biochemical analyses two decades ago28 but additional aspects of
these pathways as revealed by proteomics will highlight less obvious facettes and will guide systems
biology and help in the interpretation of future metabolomic data. Metabolomics on the other hand
will support future proteomic studies and as an outcome novel drug targets are likely to be
identified. Proteomic studies will also be useful to study further drug resistance in the field as it has
already been shown to identify proteins26, 46, 52, 54.
As a field, it seems that a common standard to deposit primary data in public repositories or the
umbrella of the EuPathDB73 initiative is wishful to enable direct interrogation of e.g. spectra by all
interested researchers. In addition, defining an agreed standard to normalize protein levels e.g.
between life cycle stages would also be helpful facilitating direct comparisons between studies.
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Figure Legend:
Figure 1. Timeline summarizing publications of Leishmania spp. proteomics or of publications
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